The Senior Manager, Access and Patient Marketing is a key contributor to Pfizer’s Endocrine brand team, supporting access and patient engagement across Ngenla and Genotropin, with a strategic emphasis on Ngenla. The role collaborates cross-functionally to execute access and patient support strategies, manage creative development and agency partnerships, and improve the treatment journey for pediatric patients and their families. The Endocrine portfolio comprises Ngenla, a once-weekly pediatric growth hormone deficiency therapy launched in June 2023, and Genotropin, first approved for pediatric growth hormone deficiency in 1987. The position reports to the US Endocrine Marketing Lead and collaborates closely with the US Endocrine Access & Patient Marketing Director. The role leads portfolio demo-pen and materials strategy and inventory management; supports patient access, affordability, continuity of care, and patient-support messaging; and uses patient and caregiver insights and data to evaluate and improve programs. It also partners with Patient Affairs on patient advocacy group strategy, aligns internal stakeholders and field teams, manages budgets and access agency relationships, and contributes to annual strategic and tactical operating plans. Responsibilities are to be carried out in accordance with Company policies and values, with strong attention to compliance. This position is hybrid and is posted in multiple locations. The annual base salary range is $124,400 to $207,400, with eligibility for a Global Performance Plan bonus target of 17.5% of base salary and a share-based long-term incentive program. Pfizer states that relocation assistance may be available based on business needs and/or eligibility. Candidates must have permanent U.S. work authorization; visa sponsorship is not available.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior